🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Microchip Technology retains Overweight rating as KeyBanc trims target amid weak outlook

EditorAhmed Abdulazez Abdulkadir
Published 07/11/2024, 10:32
MCHP
-

On Wednesday, KeyBanc Capital Markets adjusted its outlook on Microchip Technology (NASDAQ:MCHP), reducing the price target to $95 from the previous $100. Despite the lower target, the firm maintained its Overweight rating on the company's shares.

Microchip Technology recently reported its second fiscal quarter (September) results, which were in line with expectations. However, the company's guidance for the third fiscal quarter (December) was lower than anticipated. Management highlighted that while most regions and end markets are experiencing a downturn, Europe and the Industrial sector are showing particular weakness.

The company also pointed out that inventory destocking continues to be a challenge, affecting multiple levels of indirect customers. Even though the company did not definitively signal a market bottom, it did note some positive signs. These include an increase in order expedites and pull-ins, coupled with a decrease in cancellations and pushouts, which could indicate a forthcoming recovery.

In light of these developments, KeyBanc has revised its estimates and price target for Microchip Technology. The firm expressed disappointment with the recent results but recommended that investors maintain ownership of MCHP shares. KeyBanc's stance is based on the belief that the market is nearing a cyclical bottom, as suggested by the observed "green shoots" in the company's activity.

In other recent news, Microchip Technology has seen multiple adjustments to its stock outlook following its latest financial report. Truist Securities lowered its price target for the company to $71, citing high inventory levels impacting estimates, while maintaining a Hold rating. Despite a 6.4% drop in Q2 fiscal 2025 net sales to $1.241 billion, Microchip Technology reported a robust non-GAAP net income of $289.9 million.

Piper Sandler, Needham, Evercore ISI, and Raymond (NS:RYMD) James also adjusted their price targets for the company, with a general consensus leaning towards a cautious short-term view but optimism for the long-term potential. The company continued its history of consistent dividend payments, declaring a quarterly cash dividend of 45.5 cents per share.

In terms of product development, Microchip Technology launched the PIC64HX family of microprocessors for the edge computing market, expanded its Wi-Fi product line with 20 new products, and introduced the 101765 family of Voltage-Controlled SAW Oscillators for the aerospace and defense markets.

InvestingPro Insights

Recent data from InvestingPro sheds additional light on Microchip Technology's current position. The company's market capitalization stands at $39.6 billion, reflecting its significant presence in the semiconductor industry. Despite the challenges highlighted in KeyBanc's report, Microchip Technology maintains a dividend yield of 2.42%, with an impressive track record of raising its dividend for 12 consecutive years, as noted in an InvestingPro Tip.

However, the company's financial metrics reveal some concerns. The revenue for the last twelve months as of Q2 2025 was $5,496.6 million, with a substantial revenue decline of 38.55% over the same period. This aligns with the inventory destocking challenges mentioned in the article. Additionally, an InvestingPro Tip indicates that analysts anticipate a sales decline in the current year, corroborating the company's lower guidance for the upcoming quarter.

On a positive note, Microchip Technology remains profitable, with a gross profit margin of 60.32% for the last twelve months. This suggests that despite the current headwinds, the company maintains strong pricing power and operational efficiency.

For investors seeking a more comprehensive analysis, InvestingPro offers 14 additional tips on Microchip Technology, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.